美国密歇根大学2024年招聘博士后职位（药物化学用于癌症药物发现）

密西根大学（University of Michigan），也称密西根大学安娜堡校区，简称密大或UMich ，创建于1817年，校本部位于美国密西根州安娜堡市，是一所公立研究型大学，被誉为公立常春藤，入选英国政府“高潜力人才签证计划”。

Postdoctoral Fellow in Medicinal Chemistry for Cancer Drug Discovery

University of Michigan

Job Description

Postdoctoral position is available in the laboratory of Prof. Tomasz Cierpicki, University of Michigan, Ann Arbor, to develop small molecule inhibitors for targeted therapies in cancer. We are seeking for highly motivated synthetic organic chemist or medicinal chemist to join a comprehensive drug discovery program. Dr. Cierpicki lab. is conducting highly interdisciplinary research focused on pre-clinical development of novel anti-cancer drugs, which covers medicinal chemistry, structural biology, biochemical and biophysical assays, biological and animal studies. We have a strong team of synthetic chemists to support our drug-discovery efforts. The successful candidate will be involved in designing and synthesis of small molecule inhibitors targeting proteins as potential anti-cancer agents with a major focus on synthesis of heterocyclic compounds targeting protein-protein interactions relevant to cancer. The duties will include design and synthesis of new analogues of existing leads to develop biologically active compounds for testing in cancer cells and animal models of cancer. The candidate must be independent in designing synthetic routes, solving challenging synthetic problems, efficient in synthesizing targeted molecules, including multi-step synthesis.

Requirements

Applicant must have PhD in synthetic organic chemistry or medicinal chemistry and be a first author on at least 2-3 publications. This position requires extensive experience in designing synthetic routes for new classes of compounds, solving challenging synthetic problems, SAR analysis. Applicant needs an expertise in using HPLC, NMR and MS for organic chemistry applications. Excellent oral and written communication skills in English are required.

How to apply

Please submit cover letter, CV, and contact information for 2-3 references combined into one PDF file by e-mail to: tomaszc@umich.edu

Contact: Tomasz Cierpicki, PhD, Professor

Department of Pathology, University of Michigan

Ann Arbor, MI, 48109, USA

https://www.pathology.med.umich.edu/index.php?t=page&id=1473

e-mail: tomaszc@umich.edu

Relevant publications:

1. Shukla, S., et al., Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domain, Nat Chem Biol, (2021) Jul 17 (7). doi: 10.1038/s41589-021-00815-5.

2. Rogawski DS, et al., Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity. Nat Commun. (2021) May 14;12(1):2792.

3. Klossowski S, et al. Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. J Clin Invest. (2020), Feb 3;130(2):981.